Skip to main content
Peter Bergsagel, MD, Oncology, Scottsdale, AZ

PeterLeifBergsagelMD

Oncology Scottsdale, AZ

Consultant and Professor of Medicine

Dr. Bergsagel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bergsagel's full profile

Already have an account?

  • Office

    13400 E Shea Blvd
    Scottsdale, AZ 85259
    Phone+1 480-301-8000

Summary

  • Dr. Peter Bergsagel is an oncologist in Scottsdale, AZ and is affiliated with Mayo Clinic Hospital. He received his medical degree from University of Toronto Faculty of Medicine and has been in practice 33 years. He is experienced in multiple myeloma.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1985 - 1986
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 1984
  • Trinity College, University of Toronto
    Trinity College, University of TorontoB.S., 1977 - 1980

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2004 - 2026
  • CA State Medical License
    CA State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 1995 - 2006
  • WV State Medical License
    WV State Medical License 1990 - 1996
  • MD State Medical License
    MD State Medical License 1988 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Top Doctors:Arizona State Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inhibitors of the Protein Disulfide Isomerase Family for the Treatment of Multiple Myeloma  
    Peter Bergsagel, MD, Nature
  • Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
    John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
  • Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth  
    Vallabhapurapu SD, Noothi SK, Pullum DA, Lawrie CH, Pallapati R, Potluri V, Kuntzen C, Khan S, Plas DR, Orlowski RZ, Chesi M, Kuehl WM, Bergsagel PL, Karin M, Vallabha..., Nature Communications, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Interim analysis of a phase ii trial of nab-paclitaxel in patients with very advanced relapsed/refractory multiple myeloma (rr-mm)
    Rosenthal AC, Fonseca R, Mikhael J, Stewart AK, Mayo A, Chesi M, Kosiorek H, Bergsagel PL, J Clin Oncol, 1/20/2015
  • Uch-l1 synergizes with bcl6 and predicts a poor outcome in diffuse large b-cell lymphoma
    Bedekovics T, Hussain S, Feldman AL, Chesi M, Bergsagel PL, Galardy PJ, Br J Haematol, 1/1/2015
  • Targeting genetic heterogeneity in multiple myeloma through immune activation
    Chesi M, Bergsagel PL, Clin Cancer Res, 1/1/2015
  • Join now to see all

Lectures

  • A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Grant Support

  • Mouse Model Of Age-Associated Monoclonal GammopathyNational Institute On Aging2010–2012
  • Molecular Pathogenesis Of Multiple MyelomaNational Cancer Institute2009–2012
  • Comparative Pharmaco-Oncogenomics Of Myeloma Drug ResistanceNational Cancer Institute2009–2012
  • P-4: Targeting Activation Of NFKB Pathways In MMNational Cancer Institute2008–2011
  • Mouse Models Of Age-Associated Monoclonal GammopathyNational Institute On Aging2009
  • Mouse Models Of Age-Associated Monoclonal GammopathyNational Institute On Aging2005–2007
  • Mouse Models Of Age-Associated Monoclonal GammopathyNational Institute On Aging2003–2004
  • Molecular Pathogenesis Of Plasma Cell NeoplasmsNational Cancer Institute1997–2001